Debbane Raymond
Lexicon Pharmaceuticals, Inc. · Director
Debbane Raymond is listed in filings as Director at Lexicon Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Jun 4, 2026, including purchase activity. Recent filings connect the profile to Lexicon Pharmaceuticals, Inc. (LXRX). The current snapshot covers public activity from May 13, 2025 to Jun 4, 2026. Reported amounts are shown as $70.0K to $147.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $147k100k shares | BuyFeb 23, 2026 | $1.47 | $2.28 | |
| $148k100k shares | BuyFeb 20, 2026 | $1.48 | $2.28 | |
| $72k50k shares | BuyFeb 19, 2026 | $1.44 | $2.28 | |
| $176k133.7k shares | BuyFeb 18, 2026 | $1.32 | $2.28 | |
| $101k76.9k shares | BuyFeb 17, 2026 | $1.31 | $2.28 | |
| $76k58k shares | BuyFeb 13, 2026 | $1.31 | $2.28 |